Synthesis of Magnetite Nanoparticles through a Lab-On-Chip Device.
iron oxide nanoparticles
lab-on-chip
magnetite nanoparticles
microfluidics
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
08 Oct 2021
08 Oct 2021
Historique:
received:
15
08
2021
revised:
01
10
2021
accepted:
03
10
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
epublish
Résumé
Magnetite nanoparticles (MNPs) represent one of the most intensively studied types of iron oxide nanoparticles in various fields, including biomedicine, pharmaceutics, bioengineering, and industry. Since their properties in terms of size, shape, and surface charge significantly affects their efficiency towards the envisaged application, it is fundamentally important to develop a new synthesis route that allows for the control and modulation of the nanoparticle features. In this context, the aim of the present study was to develop a new method for the synthesis of MNPs. Specifically, a microfluidic lab-on-chip (LoC) device was used to obtain MNPs with controlled properties. The study investigated the influence of iron precursor solution concentration and flowed onto the final properties of the nanomaterials. The synthesized MNPs were characterized in terms of size, morphology, structure, composition, and stability. Results proved the formation of magnetite as a single mineral phase. Moreover, the uniform spherical shape and narrow size distribution were demonstrated. Optimal characteristics regarding MNPs crystallinity, uniformity, and thermal stability were obtained at higher concentrations and lower flows. In this manner, the potential of the LoC device is a promising tool for the synthesis of nanomaterials by ensuring the necessary uniformity for all final applications.
Identifiants
pubmed: 34640303
pii: ma14195906
doi: 10.3390/ma14195906
pmc: PMC8510126
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Molecules. 2021 Feb 04;26(4):
pubmed: 33557107
Molecules. 2018 Mar 02;23(3):
pubmed: 29498692
Electrophoresis. 2014 Feb;35(2-3):330-6
pubmed: 24002863
Molecules. 2013 Jun 03;18(6):6521-31
pubmed: 23736788
Int J Mol Sci. 2020 Oct 05;21(19):
pubmed: 33027980
ACS Nano. 2017 Apr 25;11(4):3496-3505
pubmed: 28272874
Nanoscale. 2020 Jul 9;12(26):13933-13947
pubmed: 32406897
Nanomaterials (Basel). 2020 Jul 30;10(8):
pubmed: 32751621
ACS Nano. 2017 Jun 27;11(6):6370-6381
pubmed: 28599110
Nanoscale Res Lett. 2013 Sep 08;8(1):381
pubmed: 24011350
Anal Chem. 2018 Aug 21;90(16):9975-9982
pubmed: 30044615
Molecules. 2020 Dec 18;25(24):
pubmed: 33353220
Electrophoresis. 2014 Feb;35(2-3):316-22
pubmed: 23857679
Antibiotics (Basel). 2018 Jun 09;7(2):
pubmed: 29890753
IEEE Trans Nanobioscience. 2019 Apr;18(2):156-169
pubmed: 30703034
Adv Drug Deliv Rev. 2019 Jan 1;138:302-325
pubmed: 30639256
Electrophoresis. 2020 Jul;41(13-14):1206-1224
pubmed: 32347555
Molecules. 2020 Jul 10;25(14):
pubmed: 32664325
Molecules. 2021 Apr 10;26(8):
pubmed: 33920270
Methods. 2021 Apr 27;:
pubmed: 33915292
Int J Mol Sci. 2013 Sep 09;14(9):18535-56
pubmed: 24022689
Methods Enzymol. 2009;465:129-41
pubmed: 19913165
Nanomedicine (Lond). 2018 Jun;13(12):1495-1512
pubmed: 29972677
Front Cell Neurosci. 2020 Feb 28;14:21
pubmed: 32184709
Electrophoresis. 2014 Sep;35(18):2673-80
pubmed: 24917513
Analyst. 2021 Feb 7;146(3):997-1003
pubmed: 33295341
ACS Omega. 2021 Feb 26;6(9):6274-6283
pubmed: 33718717